{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T05:49:15Z","timestamp":1794203355431,"version":"4.8.0"},"reference-count":107,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1053\/j.seminoncol.2009.05.002","type":"journal-article","created":{"date-parts":[[2009,8,5]],"date-time":"2009-08-05T09:30:35Z","timestamp":1249464635000},"page":"S2-S16","source":"Crossref","is-referenced-by-count":140,"special_numbering":"S2","title":["Central Nervous System Disease in Hematologic Malignancies: Historical Perspective and Practical Applications"],"prefix":"10.1053","volume":"36","author":[{"given":"Ching-Hon","family":"Pui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eckhard","family":"Thiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminoncol.2009.05.002_bib1","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.beha.2005.11.003","article-title":"History of the treatment of childhood ALL: a paradigm for cancer cure","volume":"19","author":"Simone","year":"2006","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib2","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1056\/NEJMra052603","article-title":"Treatment of acute lymphoblastic leukemia","volume":"354","author":"Pui","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib3","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1470-2045(08)70070-6","article-title":"Current management and challenges of malignant disease in the CNS in paediatric leukaemia","volume":"9","author":"Pui","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib4","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/(SICI)1097-0142(19980215)82:4<733::AID-CNCR17>3.0.CO;2-Z","article-title":"Cerebrospinal fluid cytology in patients with cancer: minimizing false-negative results","volume":"82","author":"Glantz","year":"1998","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib5","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/j.1365-2141.2004.04853.x","article-title":"Clinical follow-up indicates differential accuracy of magnetic resonance imaging and immunocytology of the cerebral spinal fluid for the diagnosis of neoplastic meningitis\u2014a single centre experience","volume":"124","author":"Zeiser","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib6","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/00004728-199007000-00007","article-title":"Neoplastic vs inflammatory meningeal enhancement with Gd-DTPA","volume":"14","author":"Phillips","year":"1990","journal-title":"J Comput Assist Tomogr"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib7","first-page":"540","article-title":"New approaches to acute lymphoblastic leukemia in adults: where do we go?","volume":"27","author":"Hoelzer","year":"2000","journal-title":"Semin Oncol"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib8","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1182\/blood-2004-05-1982","article-title":"High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for central nervous system involvement: the role of flow cytometry versus cytology","volume":"105","author":"Hegde","year":"2005","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib9","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1212\/01.wnl.0000261909.28915.83","article-title":"CSF flow cytometry greatly improves diagnostic accuracy in CNS hematologic malignancies","volume":"68","author":"Bromberg","year":"2007","journal-title":"Neurology"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib10","doi-asserted-by":"crossref","first-page":"456","DOI":"10.6004\/jnccn.2008.0037","article-title":"Central nervous system cancers","volume":"6","author":"Brem","year":"2008","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib11","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/(SICI)1097-0142(19960201)77:3<543::AID-CNCR17>3.0.CO;2-4","article-title":"A comparison of polymerase chain reaction examination of cerebrospinal fluid and conventional cytology in the diagnosis of lymphomatous meningitis","volume":"77","author":"Rhodes","year":"1996","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib12","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1212\/WNL.58.3.390","article-title":"CSF evaluation in primary CNS lymphoma patients by PCR of the CDR III IgH genes","volume":"58","author":"Gleissner","year":"2002","journal-title":"Neurology"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib13","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1080\/10428190802220527","article-title":"Intrathecal liposomal cytarabine: more friend than foe?","volume":"49","author":"Bhojwani","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib14","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJM199307293290504","article-title":"Low leukocyte counts with blast cells in cerebrospinal fluid of children with newly diagnosed acute lymphoblastic leukemia","volume":"329","author":"Mahmoud","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib15","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1200\/JCO.1996.14.1.18","article-title":"Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia","volume":"14","author":"Smith","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib16","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1200\/JCO.2003.04.096","article-title":"Diagnostic cerebrospinal fluid examination in children with acute lymphoblastic leukemia: significance of low leukocyte counts with blasts or traumatic lumbar puncture","volume":"21","author":"Burger","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib17","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1200\/JCO.1994.12.12.2594","article-title":"Low numbers of CSF blasts at diagnosis do not predict for the development of CNS leukemia in children with intermediate-risk acute lymphoblastic leukemia: a Childrens Cancer Group report","volume":"12","author":"Gilchrist","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib18","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1200\/JCO.2005.03.9727","article-title":"Prognostic significance of blasts in the cerebrospinal fluid without pleiocytosis or a traumatic lumbar puncture in children with acute lymphoblastic leukemia: experience of the Dutch Childhood Oncology Group","volume":"24","author":"te Loo","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib19","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/mpo.2950250106","article-title":"Significance of lymphoblasts in cerebrospinal fluid in newly diagnosed pediatric acute lymphoblastic malignancies with bone marrow involvement: possible benefit of dexamethasone","volume":"25","author":"van den Berg","year":"1995","journal-title":"Med Pediatr Oncol"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib20","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1182\/blood.V96.10.3381","article-title":"Traumatic lumbar puncture at diagnosis adversely affects outcome in childhood acute lymphoblastic leukemia","volume":"96","author":"Gajjar","year":"2000","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib21","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa0900386","article-title":"Treating childhood acute lymphoblastic leukemia without cranial irradiation","volume":"360","author":"Pui","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib22","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1001\/jama.288.16.2001","article-title":"Risk factors for traumatic and bloody lumbar puncture in children with acute lymphoblastic leukemia","volume":"288","author":"Howard","year":"2002","journal-title":"JAMA"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib23","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1200\/JCO.1997.15.8.2786","article-title":"Role of cranial radiotherapy for childhood T-cell acute lymphoblastic leukemia with high WBC and good response to prednisone","volume":"15","author":"Conter","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib24","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1200\/JCO.2003.10.116","article-title":"Childhood T-cell acute lymphoblastic leukemia: the Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experience","volume":"21","author":"Goldberg","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib25","first-page":"3310","article-title":"Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90","volume":"95","author":"Schrappe","year":"2000","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib26","doi-asserted-by":"crossref","first-page":"4752","DOI":"10.1182\/blood-2004-11-4544","article-title":"Pharmacogenetics of outcome in children with acute lymphoblastic leukemia","volume":"105","author":"Rocha","year":"2005","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib27","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(02)08065-0","article-title":"Polymorphism of the thymidylate synthase gene and outcome of acute lymphoblastic leukaemia","volume":"359","author":"Krajinovic","year":"2002","journal-title":"Lancet"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib28","doi-asserted-by":"crossref","first-page":"4813","DOI":"10.1200\/JCO.2007.11.8166","article-title":"High interleukin-15 expression characterizes childhood acute lymphoblastic leukemia with involvement of the CNS","volume":"25","author":"Cario","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib29","first-page":"110","article-title":"Low expression of IL-15 in adult B-lineage acute lymphoblastic leukemia is associated with central nervous system involvement at initial presentation [abstract 2389]","author":"Wu","year":"2007","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib30","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1182\/blood.V86.6.2091.bloodjournal8662091","article-title":"The value of high-dose systemic chemotherapy and intrathecal therapy for central nervous system prophylaxis in different risk groups of adult acute lymphoblastic leukemia","volume":"86","author":"Cortes","year":"1995","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib31","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1182\/blood-2005-11-4666","article-title":"Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis: results from the international ALL trial MRC UKALL XII\/ECOG E2993","volume":"108","author":"Lazarus","year":"2006","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib32","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1200\/JCO.1993.11.10.1990","article-title":"Adult acute lymphoblastic leukemia: a multicentric randomized trial testing bone marrow transplantation as postremission therapy","volume":"11","author":"Fi\u00e8re","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib33","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1200\/JCO.2000.18.3.547","article-title":"Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia","volume":"18","author":"Kantarjian","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib34","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/sj.leu.2402006","article-title":"Comparison of the L10M consolidation regimen to an alternative regimen including escalating methotrexate\/L-asparaginase for adult acute lymphoblastic leukemia: a Southwest Oncology Group study","volume":"15","author":"Petersdorf","year":"2001","journal-title":"Leukemia"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib35","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1182\/blood.V72.5.1784.1784","article-title":"Identification of risk groups for development of central nervous system leukemia in adults with acute lymphocytic leukemia","volume":"72","author":"Kantarjian","year":"1998","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib36","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1182\/blood.V87.2.495.bloodjournal872495","article-title":"Improved outcome in adult B-cell acute lymphoblastic leukemia","volume":"87","author":"Hoelzer","year":"1996","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib37","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1002\/cncr.21948","article-title":"Central nervous system recurrence in adult patients with acute lymphoblastic leukemia: frequency and prognosis in 467 patients without cranial irradiation for prophylaxis","volume":"106","author":"Sancho","year":"2006","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib38","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1182\/blood-2002-08-2454","article-title":"Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group","volume":"101","author":"Bostrom","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib39","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/j.1365-2141.2005.05509.x","article-title":"Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK Medical Research Council ALL97 randomized trial","volume":"129","author":"Mitchell","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib40","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0002-9343(77)90233-9","article-title":"Potency and duration of action of glucocorticoids","volume":"63","author":"Meikle","year":"1997","journal-title":"Am J Med"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib41","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1200\/JCO.1987.5.2.202","article-title":"Differences in cerebrospinal fluid penetration of corticosteroids: possible relationship to the prevention of meningeal leukemia","volume":"5","author":"Balis","year":"1987","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib42","doi-asserted-by":"crossref","first-page":"6489","DOI":"10.1200\/JCO.2005.01.982","article-title":"No advantage of dexamethasone over prednisolone for the outcome of standard- and intermediate-risk childhood acute lymphoblastic leukemia in the Tokyo Children's Cancer Study Group L95-14 protocol","volume":"23","author":"Igarashi","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib43","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1200\/JCO.2003.08.047","article-title":"CNS-directed therapy for childhood acute lymphoblastic leukemia: Childhood ALL Collaborative Group overview of 43 randomized trials","volume":"21","author":"Clarke","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib44","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1080\/10428190600955837","article-title":"Is mega dose of methotrexate beneficial to patients with acute lymphoblastic leukemia?","volume":"47","author":"Pui","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib45","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1182\/blood-2006-06-027714","article-title":"Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia","volume":"109","author":"Moghrabi","year":"2007","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib46","first-page":"156a","article-title":"Comparison of mercaptopurine (mp) with thioguanine (tg) and it methotrexate with it \u201ctriples\u201d (itt) in children with sr-all: results of ccg1952 [abstract 585]","volume":"100","author":"Stork","year":"2002","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib47","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(06)69558-5","article-title":"Toxicity and efficacy of 6-thioguanine versus 6-mercaptopurine in childhood lymphoblastic leukaemia: a randomised trial","volume":"368","author":"Vora","year":"2006","journal-title":"Lancet"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib48","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/pbc.20964","article-title":"Substitution of oral and intravenous thioguanine for mercaptopurine in a treatment regimen for children with standard risk acute lymphoblastic leukemia: a collaborative Children's Oncology Group\/National Cancer Institute pilot trial (CCG-1942)","volume":"49","author":"Jacobs","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib49","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1182\/blood-2005-12-011809","article-title":"Intrathecal triple therapy decreases central nervous system relapse but fails to improve event-free survival when compared with intrathecal methotrexate: results of the Children's Cancer Group (CCG) 1952 study for standard-risk acute lymphoblastic leukemia, reported by the Children's Oncology Group","volume":"108","author":"Matloub","year":"2006","journal-title":"Blood"},{"issue":"part 1 of 2","key":"10.1053\/j.seminoncol.2009.05.002_bib50","first-page":"84a","article-title":"Improved remission induction rate of childhood AML: preliminary results of the AML02 trial [abstract 275]","volume":"106","author":"Rubnitz","year":"2005","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib51","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1200\/JCO.1995.13.1.177","article-title":"Effect of body position on ventricular CSF methotrexate concentration following intralumbar administration","volume":"13","author":"Blaney","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib52","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1212\/01.wnl.0000173034.96211.1b","article-title":"Addendum to assessment: prevention of post-lumbar puncture headaches: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology","volume":"65","author":"Armon","year":"2005","journal-title":"Neurology"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib53","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1056\/NEJMra042354","article-title":"Thrombosis of the cerebral veins and sinuses","volume":"352","author":"Stam","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib54","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1542\/peds.2005-0519","article-title":"Local anesthetic and stylet styles: factors associated with resident lumbar puncture success","volume":"117","author":"Baxter","year":"2006","journal-title":"Pediatrics"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib55","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJMoa035091","article-title":"Extended follow-up of long-term survivors of childhood acute lymphoblastic leukemia","volume":"349","author":"Pui","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib56","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1200\/JCO.2005.03.3373","article-title":"Isolated CNS relapse of acute lymphoblastic leukemia treated with intensive systemic chemotherapy and delayed CNS radiation: a Pediatric Oncology Group study","volume":"24","author":"Barredo","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib57","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/cncr.10265","article-title":"Central nervous system relapse in adults with acute lymphoblastic leukemia","volume":"94","author":"Surapaneni","year":"2002","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib58","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1182\/blood-2006-05-018192","article-title":"Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12\/ECOG 2993 study","volume":"109","author":"Fielding","year":"2007","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib59","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1182\/blood.V97.11.3370","article-title":"The Societe Francaise d'Oncologie Pediatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia","volume":"97","author":"Patte","year":"2001","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib60","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1182\/blood-2004-03-0973","article-title":"The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95","volume":"105","author":"Woessmann","year":"2005","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib61","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1200\/JCO.2004.01.046","article-title":"Phase I trial of intrathecal liposomal cytarabine in children with neoplastic meningitis","volume":"22","author":"Bomgaars","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib62","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/BF02710168","article-title":"Liposomal cytarabine (DepoCyte) for the treatment of neoplastic meningitis","volume":"7","author":"Rueda Dominguez","year":"2005","journal-title":"Clin Transl Oncol"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib63","first-page":"1596","article-title":"Prolongation of drug exposure in cerebrospinal fluid by encapsulation into DepoFoam","volume":"53","author":"Kim","year":"1993","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib64","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1001\/archneur.1995.00540330094020","article-title":"Pharmacokinetics of intralumbar DTC-101 for the treatment of leptomeningeal metastases","volume":"52","author":"Chamberlain","year":"1995","journal-title":"Arch Neurol"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib65","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1200\/JCO.1999.17.10.3110","article-title":"Randomized trial of a slow release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis","volume":"17","author":"Glantz","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib66","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1054\/bjoc.2000.1574","article-title":"Intrathecal treatment of neoplastic meningitis due to breast cancer with a slow-release formulation of cytarabine","volume":"84","author":"Jaeckle","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib67","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1182\/blood-2006-08-043646","article-title":"Neurologic complications associated with intrathecal liposomal cytarabine given prophylactically in combination with high-dose methotrexate and cytarabine to patients with acute lymphocytic leukemia","volume":"109","author":"Jabbour","year":"2007","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib68","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/MPH.0b013e318041f112","article-title":"Feasibility and toxicity of intrathecal liposomal cytarabine in 5 children and young adults with refractory neoplastic meningitis","volume":"29","author":"Benesch","year":"2007","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib69","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1080\/10428190701573232","article-title":"Intrathecal liposomal cytarabine for prevention of meningeal disease in patients with acute lymphocytic leukemia and high-grade lymphoma","volume":"48","author":"McClune","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib70","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1080\/10428190802216749","article-title":"Efficacy and safety of intrathecal liposomal cytarabine for the treatment of meningeal relapse in acute lymphoblastic leukemia: experience of two pediatric institutions","volume":"49","author":"Parasole","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib71","first-page":"736","article-title":"Phase I and pharmacokinetic evaluation of thiotepa in the cerebrospinal fluid and plasma of pediatric patients: evidence for dose-dependent plasma clearance of thiotepa","volume":"49","author":"Heideman","year":"1989","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib72","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/00043426-200205000-00011","article-title":"Intrathecal thiotepa: reappraisal of an established therapy","volume":"24","author":"Fisher","year":"2002","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib73","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1053\/beha.2002.0230","article-title":"Treatment of lymphoblastic lymphoma in adults","volume":"15","author":"Hoelzer","year":"2002","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib74","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1200\/JCO.1999.17.8.2479","article-title":"CNS involvement in primary mediastinal large B-cell lymphoma","volume":"17","author":"Bishop","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib75","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1093\/annonc\/mdf175","article-title":"Central nervous system involvement following diagnosis of non-Hodgkin's lymphoma: a risk model","volume":"13","author":"Hollender","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib76","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1365-2141.2005.05703.x","article-title":"Central nervous system-directed preventative therapy in adults with lymphoma","volume":"131","author":"McMillan","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib77","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1159\/000088333","article-title":"Primary breast lymphoma: results of a controlled clinical trial","volume":"69","author":"Aviles","year":"2005","journal-title":"Oncology"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib78","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1200\/JCO.2003.11.141","article-title":"Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the International Extranodal Lymphoma Study Group","volume":"21","author":"Zucca","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib79","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1365-2141.2004.05028.x","article-title":"Ocular presentation of primary central nervous system lymphoma: diagnosis and treatment","volume":"126","author":"Hormigo","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib80","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1200\/JCO.1996.14.3.941","article-title":"CNS involvement in mantle-cell lymphoma","volume":"14","author":"Montserrat","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib81","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s002770050491","article-title":"Central nervous system involvement in patients with mantle cell lymphoma","volume":"78","author":"Oinonen","year":"1999","journal-title":"Ann Hematol"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib82","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s11060-006-9165-6","article-title":"Relapse of primary central nervous system lymphoma: clinical features, outcome and prognostic factors","volume":"80","author":"Jahnke","year":"2006","journal-title":"J Neurooncol"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib83","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/annonc\/mdh013","article-title":"Incidence and risk factors for central nervous system occurrence in elderly patients with diffuse large-B-cell lymphoma: influence of rituximab","volume":"15","author":"Feugier","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib84","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1182\/blood.V91.4.1178","article-title":"Risk factors, treatment, and outcome of central nervous system recurrence in adults with intermediate-grade and immunoblastic lymphoma","volume":"91","author":"van Besien","year":"1998","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib85","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1055\/s-2004-861534","article-title":"Prevention and treatment of central nervous system involvement by non-Hodgkin's lymphoma: a review of the literature","volume":"24","author":"Colocci","year":"2004","journal-title":"Semin Neurol"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib86","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1001\/archneur.1997.00550190044013","article-title":"Central nervous system relapse in non-Hodgkin lymphoma","volume":"54","author":"Bollen","year":"1997","journal-title":"Arch Neurol"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib87","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3109\/10428190009087024","article-title":"Predictive factors for central nervous system involvement in non-Hodgkin's lymphoma: significance of very high serum LDH concentrations","volume":"38","author":"Tomita","year":"2000","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib88","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3109\/02841869609084002","article-title":"Risk factors for central nervous system involvement in non-Hodgkins-lymphoma\u2014a multivariate analysis","volume":"35","author":"Keldsen","year":"1996","journal-title":"Acta Oncol"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib89","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1023\/A:1008394827806","article-title":"Incidence and risk factors of central nervous system relapse in histologically aggressive non-Hodgkin's lymphoma uniformly treated and receiving intrathecal central nervous system prophylaxis: a GELA study on 974 patients","volume":"11","author":"Haioun","year":"2000","journal-title":"Ann Oncol"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib90","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/annonc\/mdl327","article-title":"Incidence and risk factors of central nervous system recurrence in aggressive lymphoma\u2014a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL)","volume":"18","author":"Boehme","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib91","doi-asserted-by":"crossref","first-page":"4284","DOI":"10.1182\/blood-2003-02-0542","article-title":"Intensive conventional chemotherapy (ACVBP regimen) compared with standard CHOP for poor-prognosis aggressive non-Hodgkin lymphoma","volume":"102","author":"Tilly","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib92","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1080\/10428190290012092","article-title":"Central nervous system relapse of systemic non-Hodgkin's lymphoma: results of treatment based on high-dose methotrexate combination chemotherapy","volume":"43","author":"Bokstein","year":"2002","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib93","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.blre.2006.02.001","article-title":"CNS prophylaxis in lymphoma: who to target and what therapy to use","volume":"20","author":"Hill","year":"2006","journal-title":"Blood Rev"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib94","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00277-005-1096-3","article-title":"Retrospective study of prognostic factors in non-Hodgkin lymphoma secondarily involving the central nervous system","volume":"85","author":"Jahnke","year":"2006","journal-title":"Ann Hematol"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib95","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.bbmt.2004.09.009","article-title":"High-dose therapy and blood or marrow transplantation for non-Hodgkin lymphoma with central nervous system involvement","volume":"11","author":"Kasamon","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib96","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S1083-8791(00)70060-7","article-title":"High-dose therapy with hematopoietic cell transplantation for patients with central nervous system involvement by non-Hodgkin's lymphoma","volume":"6","author":"Alvarnas","year":"2000","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib97","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1200\/JCO.1994.12.11.2415","article-title":"Autologous bone marrow transplantation for patients with non-Hodgkin's lymphoma and CNS involvement: those transplanted with active CNS disease have a poor outcome\u2014a report by the European Bone Marrow Transplant Lymphoma Registry","volume":"12","author":"Williams","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib98","author":"Fischer"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib99","doi-asserted-by":"crossref","first-page":"606s","DOI":"10.1200\/jco.2007.25.18_suppl.12524","article-title":"High-dose methotrexate and ifosfamide for CNS relapse of aggressive lymphoma [abstract 12524]","volume":"25","author":"Fischer","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib100","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/1097-0142(19820201)49:3<586::AID-CNCR2820490331>3.0.CO;2-C","article-title":"Central nervous system involvement in non-Hodgkin's lymphoma: an analysis of 105 cases","volume":"49","author":"MacKintosh","year":"1982","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib101","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/00000421-199112000-00004","article-title":"Central nervous system involvement in patients with diffuse aggressive non-Hodgkin's lymphoma","volume":"14","author":"Bashir","year":"1991","journal-title":"Am J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib102","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3109\/10428199909058415","article-title":"Isolated central nervous system relapse in aggressive non-Hodgkin's lymphoma: the Bologna experience","volume":"32","author":"Zinzani","year":"1999","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib103","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1600-0609.1985.tb02817.x","article-title":"Meningeal involvement in non-Hodgkin's lymphoma: symptoms, incidence, risk factors and treatment","volume":"35","author":"Ersboll","year":"1985","journal-title":"Scand J Haematol"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib104","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/hon.2900080305","article-title":"Secondary central nervous system involvement by non-Hodgkin's lymphoma: the risk factors","volume":"8","author":"Liang","year":"1990","journal-title":"Hematol Oncol"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib105","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1080\/1042819031000067909","article-title":"CNS prophylaxis and treatment in non-Hodgkin's lymphoma: variation in practice and lessons from the literature","volume":"44","author":"Buckstein","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib106","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1365-2141.2005.05756.x","article-title":"Central nervous system chemoprophylaxis in non-Hodgkin lymphoma: current practice in the UK","volume":"131","author":"Cheung","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminoncol.2009.05.002_bib107","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1023\/A:1008260120532","article-title":"For which patients with aggressive non-Hodgkin's lymphoma is prophylaxis for central nervous system disease mandatory?","volume":"9","author":"Bos","year":"1998","journal-title":"Ann Oncol"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009377540900092X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009377540900092X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T05:40:45Z","timestamp":1590039645000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009377540900092X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":107,"alternative-id":["S009377540900092X"],"URL":"https:\/\/doi.org\/10.1053\/j.seminoncol.2009.05.002","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}